Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ajaib S Paintlia"'
Autor:
Carrie L Tatar, Sunita Appikatla, Denise A Bessert, Ajaib S Paintlia, Inderjit Singh, Robert P Skoff
Publikováno v:
ASN Neuro, Vol 2 (2010)
PMD (Pelizaeus-Merzbacher disease) is a rare neurodegenerative disorder that impairs motor and cognitive functions and is associated with a shortened lifespan. The cause of PMD is mutations of the PLP1 [proteolipid protein 1 gene (human)] gene. Trans
Externí odkaz:
https://doaj.org/article/bf7872d795bf4914aad48bc15cffe042
Publikováno v:
Glia. 61:1500-1517
We earlier documented that lovastatin (LOV)-mediated inhibition of small Rho GTPases activity protects vulnerable oligodendrocytes (OLs) in mixed glial cell cultures stimulated with Th1 cytokines and in a murine model of multiple sclerosis (MS). Howe
Publikováno v:
Journal of Neurochemistry. 116:508-521
Th1 cytokine-induced loss of oligodendrocytes (OLs) is associated with axonal loss in CNS demyelinating diseases such as multiple sclerosis (MS)that contributes to neurological disabilities in affected individuals. Recent studies indicated that, in a
Publikováno v:
Glia. 57:182-193
Drug combination therapies for central nervous system (CNS) demyelinating diseases including multiple sclerosis (MS) are gaining momentum over monotherapy. Over the past decade, both in vitro and in vivo studies established that statins (HMG-CoA redu
Publikováno v:
Journal of Neurochemistry. 105:956-970
Glial cells secrete proinflammatory mediators in the brain in response to exogenous stimuli such as infection and injury. Previously, we documented that systemic maternal lipopolysaccharide (LPS)-exposure at embryonic gestation day 18 causes oligoden
Publikováno v:
Experimental Neurology. 210:560-576
Cerebral white matter injury during prenatal maternal infection characterized as periventricular leukomalacia is the main substrate for cerebral palsy (CP) in premature infants. Previously, we reported that maternal LPS exposure causes oligodendrocyt
Publikováno v:
The American Journal of Pathology. 169:1012-1025
Combination therapy with multiple sclerosis (MS) therapeutics is gaining momentum over monotherapy for improving MS. Lovastatin, an HMG-CoA reductase inhibitor (statin), was immunomodulatory in an experimental autoimmune encephalomyelitis (EAE) model
Publikováno v:
The Journal of Immunology. 176:4385-4398
Th2 phenotype cytokine, IL-4, plays an important role in the regulation of Th1 cell responses and spontaneous remission of inflammatory CNS demyelinating diseases such as multiple sclerosis (MS). In this study we demonstrate IL-4-induced down-regulat
Autor:
Avtar K. Singh, Inderjit Singh, Miguel A. Contreras, Manjeet K. Paintlia, Romesh Stanislaus, Ehtishamul Haq, Mushfiquddin Khan, Ajaib S. Paintlia
Publikováno v:
Brain Research. 1022:1-11
Peroxisomes are ubiquitous subcellular organelles and abnormality in their biogenesis and specific gene defects leads to fatal demyelinating disorders. We report that neuroinflammatory disease in brain of experimental autoimmune encephalomyelitis (EA
Autor:
Avtar K. Singh, Manjeet K. Paintlia, Anne G. Gilg, Ernest Barbosa, Romesh Stanislaus, Ajaib S. Paintlia, Inderjit Singh
Publikováno v:
Journal of Neuroscience Research. 77:63-81
The attenuation of experimental autoimmune encephalomyelitis (EAE) by Lovastatin (LOV) has now been well established. The present study was designed to explore the global effect of LOV treatment on expression of immune-related genes in lumbar spinal